Pro Medicus (ASX:PME) shines amid tech sell off: All Ordinaries (ASX:XAO) falls
Drew Meredith, CFP
September 27, 2023
Pro Medicus Limited (ASX: PME) was a standout, adding 12.4%.
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Pro Medicus Limited (ASX: PME) was a standout, adding 12.4%.
Here’s today’s The Match Out report from Market Matters’ James
The Resmed CDI (ASX: RMD) share price is down over
Marcus Today does Technical Scans every day, and on 15
Here’s today’s The Match Out report from Market Matters’ James
Here’s today’s The Match Out report from Market Matters’ James
The Resmed CDI (ASX: RMD) share price was crushed after
The Cochlear Limited (ASX: COH) share price bounced dramatically higher
S&P/ASX 200 (ASX:XJO) managed a 0.2% gain on Friday, overcoming
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
